There were 290 press releases posted in the last 24 hours and 437,640 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Diffusion Pharmaceuticals Presents Early Findings Showing Increased Survival in Lead-in Portion of Phase 3 Glioblastoma Study with TSC plus Standard of Care

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image